Results 31 to 40 of about 37,090 (310)

What Are Optimal Blood Pressure Targets for Patients with Hypertension and Chronic Kidney Disease? [PDF]

open access: yes, 2015
To maximize the risk benefit ratio of blood pressure control in people with chronic kidney diseases (CKD), a number of guidelines provide recommendations on optimal blood pressure (BP) targets in CKD.
Agarwal, Rajiv, Modi, Gopesh K.
core   +1 more source

Proteinuria in Primary and Secondary Renal Diseases [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2012
Proteinuria is a strong indicator of kidney disease. Various pathological conditions such as diabetes mellitus, cardiovascular disease and hypertension have been shown to provoke secondary kidney problems and significant proteinuria.
Anuradha B. Patil   +2 more
doaj  

Novel Omega-3 Fatty Acid Epoxygenase Metabolite Reduces Kidney Fibrosis. [PDF]

open access: yes, 2016
Cytochrome P450 (CYP) monooxygenases epoxidize the omega-3 polyunsaturated fatty acid (PUFA) docosahexaenoic acid into novel epoxydocosapentaenoic acids (EDPs) that have multiple biological actions.
Hammock, Bruce D   +5 more
core   +3 more sources

Proanthocyanidin offers protection against diabetic nephropathy: elucidation of its mechanism of action using animal models

open access: yesPharmaceutical Biology
Context Diabetic nephropathy (DN) is a major complication of diabetes mellitus and is the leading cause of kidney disease in patients undergoing renal replacement therapy.
Dengpiao Xie   +3 more
doaj   +1 more source

Pathology identifies glomerular treatment targets in diabetic nephropathy

open access: yesKidney Research and Clinical Practice, 2018
The development of the glomerular injury in diabetic nephropathy involves interactions between podocytes, endothelium, and the mesangium. Loss of podocytes is an early and critical step in the development of diabetic nephropathy, and analysis of ...
Charles E. Alpers, Kelly L. Hudkins
doaj   +1 more source

Sarcopenia in diabetic nephropathy: a cross-sectional study

open access: yesRomanian Journal of Internal Medicine, 2018
Objective. To investigate the relationship between sarcopenia and diabetic nephropathy.
Çeliker Meral   +2 more
doaj   +1 more source

Urinary transferrin as an early biomarker of diabetic nephropathy [PDF]

open access: yesVojnosanitetski Pregled, 2019
Background/Aim. Diabetic nephropathy is one of the leading cause of chronic kidney disease and end-stage renal disease. It occurs in 20%–40% of patients with diabetes mellitus and microalbuminuria is still considered as the first sign of diabetic ...
Terzić Brankica   +9 more
doaj   +1 more source

HIV-related nephropathy: A South African perspective [PDF]

open access: yes, 2005
Human immunodeficiency virus (HIV)-associated nephropathy (HIVAN) is an important cause of renal failure in those of African origin. A number of other kidney diseases occur in HIV-positive patients.
Gerntholtz, T.E.   +2 more
core   +1 more source

A stepwise data interpretation process for renal amyloidosis typing by LMD-MS

open access: yesBMC Nephrology, 2022
Backgrounds Systemic amyloidosis is classified according to the deposited amyloid fibril protein (AFP), which determines its best therapeutic scheme. The most common type of AFP found are immunoglobulin light chains.
Ming Ke   +4 more
doaj   +1 more source

Single‐Cell Dissection of the Biological Function and Molecular Features Underlying the Micropeptide LSMEM1 in Kidney

open access: yesAdvanced Science, EarlyView.
LSMEM1, an evolutionarily conserved micropeptide with extreme hydrophobicity (aliphatic index═113) and dynamic amphiphilicity (GRAVY═0.017), features a strong α‐helical transmembrane anchor (residues 64‐86). Single‐cell analysis reveals its critical role in renal lipid homeostasis.
Peimin Liu   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy